#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenomatous polyposis coli SAPHO syndrome Acute on chronic liver failure Vernal keratoconjunctivitis Meningitis meningococcal Partial lipodystrophy Cortical dysplasia Neurotrophic keratopathy Haemophilia A with anti factor VIII Bulbospinal muscular atrophy congenital Cutaneous T-cell lymphoma stage I CDKL5 deficiency disorder Retinal artery occlusion Glomerulonephritis minimal lesion Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Trials in Disease Factor VIII deficiency – Diagnostics Undifferentiated sarcoma – Life with Disease Familial haemophagocytic lymphohistiocytosis – Treatment Glycogen storage disease type V – Diagnostics Marfan’s syndrome – Diagnostics Bronchiolitis obliterans syndrome Lysosomal storage disorder – Treatment Prolymphocytic leukaemia – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-16F-116 Zidovudine Tisotumab Vedotin Abatacept L-Tryptophan Fluorodopa (18F) Benzylpenicillin Thalidomide E2814 GSK5458514 Azd8421 Tildacerfont Abacavir Sulfate Atezolizumab Jk06 Somatropin Gandotinib Azd4831 Filgrastim Paracetamol Dc More therapies…

    Learn about Your Condition

    Intestinal obstruction Metastases to rectum Pemphigus Lung adenocarcinoma Anal cancer stage II Postprandial hypoglycaemia Red blood cell abnormality Mast cell activation syndrome Nasopharyngeal cancer Skin papilloma Congenital myopathy Colonoscopy Pertussis Erythema multiforme Sleep disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Malignant melanoma

  • Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Retroviral Vector Containing The Common Gamma Chain Cdna
    The Netherlands

  • Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Head and neck cancer
    • Breast cancer
    Investigated Drugs:
    • Perflubutane
    The Netherlands

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Malignant melanoma
    • Endometrial cancer
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Microsatellite instability cancer
    • Cervix carcinoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    The Netherlands

  • Study on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Dabrafenib
    • Binimetinib
    • Encorafenib
    Denmark

  • Study of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Cobimetinib
    • Vemurafenib
    • Atezolizumab
    Italy
Previous Page
1 2 3 4 5 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!